Detalles de la búsqueda
1.
Improved glycaemic control and weight benefit with iGlarLixi versus insulin glargine 100 U/mL in Chinese people with type 2 diabetes advancing their therapy from basal insulin plus oral antihyperglycaemic drugs: Results from the LixiLan-L-CN randomized controlled trial.
Diabetes Obes Metab
; 24(11): 2182-2191, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35762489
2.
Efficacy and safety of a single intra-articular injection of 6 ml Hylan G-F 20 compared to placebo in Chinese patients with symptomatic knee osteoarthritis : C-SOUND study, a 26-week multicenter double-blind randomized placebo-controlled trial in China.
BMC Musculoskelet Disord
; 22(1): 428, 2021 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33964907
Resultados
1 -
2
de 2
1
Próxima >
>>